检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:桑甜甜[1] 曹青[1] 王飞[1] 黄黎亚[1] 王玉强[1] 陈书艳[1] 刘芳[1] 张建军[2]
机构地区:[1]上海交通大学医学院附属新华医院老年医学科,上海200092 [2]上海市浦东新区公利医院心内科,上海200135
出 处:《现代生物医学进展》2014年第24期4626-4629,共4页Progress in Modern Biomedicine
基 金:国家自然科学基金项目(30973152;81270205)
摘 要:目的:观察FOXO3a(forkhead box O3a)的活性改变对内皮祖细胞(endothelial progenitor cells,EPCs)增殖和细胞周期相关蛋白表达的影响。方法:将携带突变激活FOXO3a基因的腺病毒载体Ad-TM(triple mutant)-FOXO3a和阴性对照腺病毒载体Ad-GFP体外感染人脐血来源的EPCs。观察EPCs形态学改变,CCK-8分析转染后EPCs增殖情况,Western blot检测FOXO3a蛋白、细胞周期相关蛋白p27kip1以及CDK2的表达水平。结果:构建了的2种腺病毒相关载体被成功转染。形态学改变方面,Ad-TM-FOXO3a组EPCs细胞生长缓慢,集落不明显;Western blot和CCK-8结果显示,Ad-TM-FOXO3a转染组与阴性对照组相比,EPCs增殖被抑制,FOXO3a与p27kip1蛋白过表达,CDK2表达下调。结论:FOXO3a可能通过上调p27kip1蛋白表达,下调CDK2表达,以抑制EPCs增殖。Objective: To investigate the effects of FOXO3a overexpression on the proliferation of endothelial progenitor cells (EPCs) and the expression of the cell cycle regulatory proteins. Methods: Two constructed recombinant adenovirus vectors, Ad-TM (triple mutant)-FOXO3a and the control Ad-GFP, were transfected into EPCs from human cord blood in vitro. The changes in cell morphology and proliferation of transfected EPCs were detected by fluorescent microscope and CCK-8 assay, respectively. The protein expression changes of FOXO3a, cell cycle regulatory proteins p27kipl and CDK2 were assessed by Western blot. Results: The both recombinant adenovirus vectors were successfully transfeeted into EPCs. The results demonstrated that compared with control group, in the Ad-TM-FOXO3a group had the overexpressed-FOXO3a, while cell division proceeded slowly and proliferation EPCs was significantly inhibited; Meanwhile p27kipl were upregulated while CDK2 expression was downregulated. Conclusion: FOXO3a may inhibit proliferation of EPCs via up-regulating the expression ofp27kipl and down-regulating the expression of CDK2.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:13.59.173.30